prikaz prve stranice dokumenta Personalizing health care: feasibility and future implications
  Preuzmi
PDF 690.72 KB
Znanstveni rad - Pregledni rad
Personalizing health care: feasibility and future implications
BMC Medicine, 11 (2013), 1; 179. https://doi.org/10.1186/1741-7015-11-179
Godman, Brian; Finlayson, Alexander E; Cheema, Parneet K; Zebedin-Brandl, Eva; Gutiérrez-Ibarluzea, Inaki; Jones, Jan; Malmström, Rickard E; Asola, Elina; Baumgärtel, Christoph; Bennie, Marion; Bishop, Iain; Bucsics, Anna; Campbell, Stephen; Diogene, Eduardo; Ferrario, Alessandra; Fürst, Jurij; Garuoliene, Kristina; Gomes, Miguel; Harris, Katharine; Haycox, Alan; Herholz, Harald; Hviding, Krystyna; Jan, Saira; Kalaba, Marija; Kvalheim, Christina; Laius, Ott; Lööv, Sven-Ake; Malinowska, Kamila; Martin, Andrew; McCullagh, Laura; Nilsson, Fredrik; Paterson, Ken; Schwabe, Ulrich; Selke, Gisbert; Sermet, Catherine; Simoens, Steven; Tomek, Dominik; Vlahović-Palčevski, Vera; Voncina, Luka; Wladysiuk, Magdalena; van Woerkom, Menno; Wong-Rieger, Durhane; Zara, Corrine; Ali, Raghib; Gustafsson, Lars L Više autora...

Citirajte ovaj rad

Godman, B., Finlayson, A. E., Cheema, P. K., Zebedin Brandl, E., Gutiérrez Ibarluzea, I., Jones, J. ... Gustafsson, L. L. (2013). Personalizing health care: feasibility and future implications. BMC Medicine, 11. (1). doi: 10.1186/1741-7015-11-179

Godman, Brian, et al. "Personalizing health care: feasibility and future implications." BMC Medicine, vol. 11, br. 1, 2013. https://doi.org/10.1186/1741-7015-11-179

Godman, Brian, Alexander E Finlayson, Parneet K Cheema, Eva Zebedin Brandl, Inaki Gutiérrez Ibarluzea, Jan Jones, Rickard E Malmström, et al. "Personalizing health care: feasibility and future implications." BMC Medicine 11, br. 1 (2013). https://doi.org/10.1186/1741-7015-11-179

Godman, B., et al. (2013) 'Personalizing health care: feasibility and future implications', BMC Medicine, 11(1). doi: 10.1186/1741-7015-11-179

Godman B, Finlayson AE, Cheema PK, Zebedin Brandl E, Gutiérrez Ibarluzea I, Jones J, i sur.. Personalizing health care: feasibility and future implications. BMC Medicine [Internet]. 2013. [pristupljeno 06.05.2024.];11(1). doi: 10.1186/1741-7015-11-179

B. Godman, et al., "Personalizing health care: feasibility and future implications", BMC Medicine, vol. 11, br. 1, 2013. [Online]. Dostupno na: https://urn.nsk.hr/urn:nbn:hr:184:659238. [Citirano: 06.05.2024.]

Za citiranje koristite ovu mrežnu adresu: https://urn.nsk.hr/urn:nbn:hr:184:659238
Prijavite se u repozitorij kako biste mogli spremiti objekt u svoju listu.
Podaci o radu
Naslov (engleski)Personalizing health care: feasibility and future implications
AutorBrian Godman
AutorAlexander E Finlayson
AutorParneet K Cheema
AutorEva Zebedin-Brandl
AutorInaki Gutiérrez-Ibarluzea
AutorJan Jones
AutorRickard E Malmström
AutorElina Asola
AutorChristoph Baumgärtel
AutorMarion Bennie
AutorIain Bishop
AutorAnna Bucsics
AutorStephen Campbell
AutorEduardo Diogene
AutorAlessandra Ferrario
AutorJurij Fürst
AutorKristina Garuoliene
AutorMiguel Gomes
AutorKatharine Harris
AutorAlan Haycox
AutorHarald Herholz
AutorKrystyna Hviding
AutorSaira Jan
AutorMarija Kalaba
AutorChristina Kvalheim
AutorOtt Laius
AutorSven-Ake Lööv
AutorKamila Malinowska
AutorAndrew Martin
AutorLaura McCullagh
AutorFredrik Nilsson
AutorKen Paterson
AutorUlrich Schwabe
AutorGisbert Selke
AutorCatherine Sermet
AutorSteven Simoens
AutorDominik Tomek
AutorVera Vlahović-Palčevski
AutorLuka Voncina
AutorMagdalena Wladysiuk
AutorMenno van Woerkom
AutorDurhane Wong-Rieger
AutorCorrine Zara
AutorRaghib Ali
AutorLars L Gustafsson
Autorova ustanovaSveučilište u Rijeci
Medicinski fakultet
(Katedra za farmakologiju)
Znanstveno / umjetničko
područje, polje i grana		BIOMEDICINA I ZDRAVSTVO
Javno zdravstvo i zdravstvena zaštita
Znanstveno / umjetničko
područje, polje i grana		BIOMEDICINA I ZDRAVSTVO
Kliničke medicinske znanosti
Klinička farmakologija s toksikologijom
Sažetak (engleski)
Considerable variety in how patients respond to treatments, driven by differences in their geno- and/ or phenotypes, calls for a more tailored approach. This is already happening, and will accelerate with developments in personalized medicine. However, its promise has not always translated into improvements in patient care due to the complexities involved. There are also concerns that advice for tests has been reversed, current tests can be costly, there is fragmentation of funding of care, and companies may seek high prices for new targeted drugs. There is a need to integrate current knowledge from a payer's perspective to provide future guidance. Multiple findings including general considerations; influence of pharmacogenomics on response and toxicity of drug therapies; value of biomarker tests; limitations and costs of tests; and potentially high acquisition costs of new targeted therapies help to give guidance on potential ways forward for all stakeholder groups. Overall, personalized medicine has the potential to revolutionize care. However, current challenges and concerns need to be addressed to enhance its uptake and funding to benefit patients.
Ključne riječi (engleski)
Jezikengleski
Vrsta publikacijeZnanstveni rad - Pregledni rad
Status objaveObjavljen
Vrsta recenzijeRecenziran - međunarodna recenzija
Verzija publikacijeObjavljena verzija rada (izdavačev PDF)
Naslov časopisaBMC Medicine
Brojčani podacivol. 11, br. 1, 179
e-ISSN1741-7015
DOIhttps://doi.org/10.1186/1741-7015-11-179
URN:NBNurn:nbn:hr:184:659238
Datum objave publikacije2013
URL dokumentahttp://bmcmedicine.biomedcentral.com/articles/10.1186/1741-7015-11-179
Vrsta resursaTekst
Prava pristupaOtvoreni pristup
Uvjeti korištenjaIkona licence Imenovanje-Bez prerada 4.0 međunarodna (CC BY-ND 4.0)
Datum i vrijeme pohrane2021-03-10 11:38:36